37
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Dual Role of Serum Soluble E-cadherin as a Biological Marker of Metastatic Development in Gastric Cancer

, , , , , & show all
Pages 850-855 | Published online: 08 Jul 2009

  • Streit M, Schmidt R, Hilgenfeld RU, Thiel E, Kreuser BD. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. J Mol Med 1996;74:253-68.
  • Vestweber D, Kemler R. Some structural and functional aspects of the cell adhesion molecule ovomorulin. Cell Differ 1984;15: 269-73.
  • Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-5.
  • Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecules ovomorulin associates with three independent proteins structurally related in different species. EMBO J 1989;8:1711-7.
  • Dogan A, Wang ZD, Spencer J. B-cadherin expression in intestinal epithelium. J Clin Pathol 1995;48:143-6.
  • Si HX, Tsao SW, Lam KY. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett 2001;173:71-8.
  • Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997;112:46-54.
  • Nigam AK, Savage FJ, Boulos PB, Stamp GW, Liu D, Pignatelli M. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993;68:507-14.
  • Endo K, Ueda T, Ueyama J, Ohta T, Terada T. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 2000;31:558-65.
  • Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol 1994;174:243-8.
  • Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, et al. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol 1995;8:177-90.
  • Damsky CH, Richa J, Solter D, Knudsen K, Buck CA. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell 1983; 34:455-66.
  • Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994;69:580-5.
  • Matsuyoshi N, Tanaka T, Toda K, Okamoto H, Furukawa F, Imamura S. Soluble E-cadherin: a novel cutaneous disease marker. Br J Dermatol 1995;132:745-9.
  • Pittard AJ, Banks RE, Galley HF, Webster NR. Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth 1996;76:629-31.
  • Griffiths TR, Brotherick I, Bishop RI, White MD, McKenna DM, Home CH, et al. Cell adhesion molecules in bladder cancer: soluble E-cadherin correlates with predictors of recurrence. Br J Cancer 1996;74:579-84.
  • Gofuku J, Shiozaki H, Doki Y, Inoue M, Hirao M, Fukuchi N, et al. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer 1998;78:1095-101.
  • Chan AOO, Lam SK, Chu KM, Lam CM, Kwok B, Leung SY, et al. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 2001;48:808-11.
  • Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, et al. Pathology and prognosis of gastric carcinoma. Cancer 1992;70:1030-7.
  • Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 1965;64:31-49.
  • Keller G, Vogelsang H, Becker I, Hutter J, Ott K, Candidus S, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin gene mutation. Am J Pathol 1999;155:337-42.
  • Ebert M, Malfertheiner P. Pathogenesis of sporadic and familial gastric cancer: implications for clinical management and cancer prevention. APT 2002;16:1059-66.
  • Amorosi A, Bianchi S, Buiatti E, Cipriani F, Palli D, Zampi G. Gastric cancer in a high-risk area in Italy. Histopathologjc Patterns according to Lauren's classification. Cancer 1988;62: 2191-6.
  • Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845-52.
  • Schandl L, Ebert MPA, Malfertheiner P. Cadherins and catenins in inflammation and oncogenesis. Digest Liver Dis 2000;Suppl 3;32:8184-7.
  • Vleminckx K, Vakaet L, Marcel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasive suppressor role. Cell 1991;66:107-19.
  • Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, et al. Circulating soluble adhesion molecules Ecadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-I) in patients with gastric cancer. Br J Cancer 1997;76:1398-404.
  • Perry I, Tselepis C, Hoyland J, Iqbal TH, Scott D, Sanders SA, et al. Reduced cadherin/catenin complex expression in celiac disease can be reproduced in vitro by cytokine stimulation. Lab Invest 1999;79:1489-9.
  • Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, et al. Release of an invasion promoter E-cadherin fragment ny matrilysin and stromerysin-1. J Cell Sci 2001;114: 111-8.
  • Livingstone JI, Yasui W, Tahara E, Wastell C. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. Br J Cancer 1995;72:976-80.
  • Teh M, Lee YS. Intestinal and diffuse carcinoma of the stomach among the ethnic and dialect groups in Singapore. Cancer 1987; 60:921-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.